Dalibor Blazek

7PUBLICATIONS
15CO-AUTHORS
Proteomics and intermolecular interactions (excl. medical proteomics)Molecular targetsIndustrial molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 28, 2026
Phosphorylation of SF3B1 by CDK11 orchestrates spliceosome activation via SNIP1-dependent RES complex recruitment.

Pavla Gajdušková, Igor Ruiz de Los Mozos, Milan Hluchý

|Dec 22, 2025
CDK7-CDK11 axis in spliceosome regulation and pre-mRNA splicing.

Michal Rájecký, Pavla Gajdušková, Peter Maník

|Mar 01, 2023
Therapeutic potential of CDK11 in cancer.

Dalibor Blazek

|Sep 14, 2022
CDK11 regulates pre-mRNA splicing by phosphorylation of SF3B1.

Milan Hluchý, Pavla Gajdušková, Igor Ruiz de Los Mozos

|Jul 28, 2021
CDK12: cellular functions and therapeutic potential of versatile player in cancer.

Kveta Pilarova, Jan Herudek, Dalibor Blazek

|May 06, 2020
CDK11 is required for transcription of replication-dependent histone genes.

Pavla Gajdušková, Igor Ruiz de Los Mozos, Michal Rájecký

Pageof 2

Frequent Collaborators

3 joint publications

Igor Ruiz de Los Mozos

3 joint publications

Caroline C Friedel

1 joint publications

Anil Paul Chirackal Manavalan

1 joint publications

Jan Oppelt